Paragon Care Limited Cash Flow Conversion Efficiency
Paragon Care Limited cash flow conversion efficiency. Based on the latest financial reports, Paragon Care Limited (PXS) has a cash flow conversion efficiency ratio of 0.031x as of June 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€7.58 Million ≈ $8.87 Million USD) by net assets (€242.34 Million ≈ $283.32 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Paragon Care Limited (2014–2023)
Cash flow conversion efficiency of Paragon Care Limited from 2014 to 2023. This chart illustrates how Paragon Care Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Paragon Care Limited for real-time trading data and today's change.
Paragon Care Limited Cash Flow Conversion Ratio Explained
Paragon Care Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Paragon Care Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Paragon Care Limited ranked by their cash flow conversion efficiency. Also see PXS market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BlackRock Long-Term Municipal Advantage Trust
NYSE:BTA
|
0.021x |
|
Dmc Global Inc
NASDAQ:BOOM
|
-0.034x |
|
Silver X Mining Corp
V:AGX
|
0.051x |
|
Zhejiang Zone King Environmental Sci&Tech Co Ltd
SHG:688701
|
0.069x |
|
American Resources Corp Class A
NASDAQ:AREC
|
-0.127x |
|
Ontex Group NV
BR:ONTEX
|
0.072x |
|
NTT System SA
WAR:NTT
|
0.057x |
|
South Logistics JSC
VN:STG
|
-0.009x |
Annual Cash Flow Conversion Efficiency for Paragon Care Limited (2014–2023)
The table below shows the annual cash flow conversion efficiency of Paragon Care Limited from 2014 to 2023. Review how much free cash does Paragon Care Limited generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-06-30 | €251.96 Million ≈ $294.56 Million |
€17.75 Million ≈ $20.75 Million |
0.070x | -10.30% |
| 2022-06-30 | €242.34 Million ≈ $283.32 Million |
€19.03 Million ≈ $22.25 Million |
0.079x | -65.25% |
| 2021-06-30 | €121.52 Million ≈ $142.07 Million |
€27.46 Million ≈ $32.11 Million |
0.226x | +379.96% |
| 2020-06-30 | €112.28 Million ≈ $131.27 Million |
€5.29 Million ≈ $6.18 Million |
0.047x | +682.01% |
| 2019-06-30 | €192.32 Million ≈ $224.84 Million |
€1.16 Million ≈ $1.35 Million |
0.006x | -86.45% |
| 2018-06-30 | €170.14 Million ≈ $198.91 Million |
€7.56 Million ≈ $8.84 Million |
0.044x | -69.36% |
| 2017-06-30 | €82.69 Million ≈ $96.67 Million |
€11.99 Million ≈ $14.02 Million |
0.145x | +35.98% |
| 2016-06-30 | €72.77 Million ≈ $85.08 Million |
€7.76 Million ≈ $9.07 Million |
0.107x | +171.00% |
| 2015-06-30 | €20.58 Million ≈ $24.06 Million |
€809.87K ≈ $946.83K |
0.039x | +134.35% |
| 2014-06-30 | €18.21 Million ≈ $21.29 Million |
€-2.09 Million ≈ $-2.44 Million |
-0.115x | -- |
About Paragon Care Limited
Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provi… Read more